
| HOME | INTERACTIVE | INFORMATION | PLEDGE | ABOUT US | LINKS |
| WHAT TTP MEANS | TTP RESEARCH |
The
COBE Spectra Apheresis System:
This
machine can separate and collect blood components from both donors and patients.
From donors blood products can be collected for
transfusion to patients.
If
desired, plasma can be collected concurrently
with platelets but this has been dropped in the UK because of the minute risk of
the transmission of CJD.
Collected plasma is available for use as plasma
or fresh frozen plasma.
Alternatively, it may be used as source plasma
for further processing into Factor XII and Factor IX concentrates (clotting
factors). The
machine can be programmed to collect platelets in a pure form, i.e. virtually
free of white cells(to minimise the risk of disease transmission) for
transfusion to patients with thrombocytopaenia (lack of platelets)
For
patients undergoing therapeutic procedures, the system can be used to exchange
or deplete blood components. In addition it can be used for the collection
of plasma or platelets form patients who will later require transfusion of those
blood products and particularly want their own products only.
The
system can be used to perform therapeutic plasma exchange on patients with
autoimmune diseases (antibodies which attack own tissue or platelets) or for
patients about to undergo a transplant operation. It can be used to
perform red blood cell exchange on patients with haematological disorders such
as sickle cell anaemia and thalassemia (where red cells contain the wrong type
of haemoglobin), for which red blood cells would be typically used as the
replacement fluid, and on patients with polycythaemia (too many red cells) or
hamochromatosis (too much iron), for which salt solution or albumin would
typically be used as the replacement fluid. The system can also be used to
perform therapeutic platelet depletions from patients with thrombocytosis (too
many platelets).
Finally
the system can be used to harvest peripheral blood stem cells (immature blood
cells which can be used in bone marrow transplants in patients with leukaemia)
after their mobilisation into the general circulation with some plasma so the
product can be frozen for future use. It can also be used for white cells
harvests from normal donors (for transfusion to individuals with overwhelming
infection or lack of white cells after chemotherapy) or simply to remove excess
white cells (in people with leukaemia).
This explanation has beeb kindly written for us by Dr Verjee.
THE GROUP MEMBERS ARE NOT MEDICAL PROFESSIONALS. YOU MUST SEEK MEDICAL ADVICE IF YOU HAVE ANY CONCERNS REGARDING TTP.